Metraipolis › archive › dc_6a326d4975fa

MEF2C is a potential prognostic biomarker for osteosarcoma — Europe PMC PMID:40922352

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40922352
DOI: 10.1097/md.0000000000044313
License (as archived): solo-consultazione
Archived: 2026-11-10T05:13:00.840Z
SHA-256 of the archived text: 20abe0c00de8e252d9ca991da653cfc85bf4e0a2720b53db1cb5d09a33ef9158
Stable URL of this page: https://metraipolis.com/documento/dc_6a326d4975fa

How to cite

MEF2C is a potential prognostic biomarker for osteosarcoma — Europe PMC PMID:40922352 — Europe PMC (en), https://europepmc.org/article/MED/40922352 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6a326d4975fa (Metraipolis archive dc_6a326d4975fa, sha256 20abe0c00de8e252d9ca991da653cfc85bf4e0a2720b53db1cb5d09a33ef9158)

BibTeX

@misc{dc6a326d4975fa,
  title = {MEF2C is a potential prognostic biomarker for osteosarcoma — Europe PMC PMID:40922352},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40922352},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6a326d4975fa; sha256 20abe0c00de8e252d9ca991da653cfc85bf4e0a2720b53db1cb5d09a33ef9158},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40922352. Agents can read the archived copy with the MCP tool read_document.